Clivatuzumab Biosimilar – Anti-MUC1, CD227 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameClivatuzumab Biosimilar - Anti-MUC1, CD227 mAb - Research Grade
SourceCAS 1462876-11-4
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsClivatuzumab,hPAM4,hPAM4 IgG-DOTA,hPAM4-DOTA,MUC1, CD227,anti-MUC1, CD227
ReferencePX-TA1390
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Clivatuzumab Biosimilar - Anti-MUC1, CD227 mAb - Research Grade

General information on Anti-MUC1/CD227[Homo sapiens] (Clivatuzumab) Monoclonal Antibody

Clivatuzumab is investigated for the treatment of Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Clivatuzumab Biosimilar – Anti-MUC1, CD227 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Cell surface glycoprotein MUC18(MCAM)
Antigen

Cell surface glycoprotein MUC18(MCAM)

PX-P4862 210€
MUC16 recombinant protein
Antigen

MUC16 recombinant protein

PX-P5181 420€
Human MUC17 recombinant protein
Antigen

Human MUC17 recombinant protein

PX-P6035 385€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products